MPM Oncology Impact Management GP LLC, Director, 10% Owner at iTeos Therapeutics, Inc. (ITOS), bought 1,589,230 shares at $19.00 ($6.1M) on 2020-07-28, disclosed to the SEC on 2020-07-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,269,230 | $0 | 0.0% |
| 2 | $19.00 | 1,121 | $21K | 0.4% |
| 3 | $19.00 | 3,020 | $57K | 0.9% |
| 4 | $19.00 | 3,096 | $59K | 1.0% |
| 5 | $19.00 | 5,994 | $114K | 1.9% |
| 6 | $19.00 | 56,814 |
| $1.1M |
| 17.8% |
| 7 | $19.00 | 89,955 | $1.7M | 28.1% |
| 8 | $19.00 | 160,000 | $3.0M | 50.0% |
| Total | $3.83 avg | 1,589,230 | $6.1M | 100% |
| Filing → |
| HARP | SELL | 2021-05-20 | $2.0M | — | Filing → |
| HARP | SELL | 2021-05-17 | $520K | — | Filing → |
| HARP | SELL | 2021-05-04 | $14.7M | — | Filing → |